Virtus ETF Advisers’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.1K Sell
83
-12
-13% -$3.25K 0.01% 439
2025
Q4
$23.8K Hold
95
0.01% 433
2025
Q3
$27.3K Sell
95
-845
-90% -$226K 0.02% 415
2025
Q2
$247K Buy
+940
New +$229K 0.15% 173
2022
Q4
Sell
-3,174
Closed -$559K 468
2022
Q3
$559K Buy
3,174
+1
+0% +$205 0.22% 195
2022
Q2
$639K Buy
+3,173
New +$676K 0.24% 167

Other funds holding LH

Virtus ETF Advisers's LH Position: Q1 2026 in Review

Virtus ETF Advisers reduced its Labcorp (LH) stake by 13% in Q1 2026, selling an estimated $3.25K and leaving 83 shares worth $22.1K. The position accounts for 0.01% of the portfolio, ranked #439.

Virtus ETF Advisers first reported a position in LH in Q2 2022 and has held it in 6 quarters since. The position peaked at $639K in Q2 2022. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Virtus ETF Advisers held 83 shares of Labcorp worth $22.1K as of Q1 2026.
  • Virtus ETF Advisers sold 12 Labcorp shares in Q1 2026, an estimated $3.25K.
  • Labcorp made up 0.01% of Virtus ETF Advisers's portfolio in Q1 2026, its #439 holding.
  • Virtus ETF Advisers first reported a position in Labcorp in Q2 2022 and has held it in 6 quarters since.
  • Virtus ETF Advisers's Labcorp position peaked at $639K in Q2 2022.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Virtus ETF Advisers's 13F filing for Q1 2026, filed 14 May 2026.